Janux Therapeutics, Inc. (JANX)
13.80
-0.03
(-0.22%)
USD |
NASDAQ |
Dec 31, 16:00
13.74
-0.06
(-0.43%)
After-Hours: 20:00
Janux Therapeutics Free Cash Flow: -71.40M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Stoke Therapeutics, Inc. | 52.37M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| MannKind Corp. | 42.74M |
| Madrigal Pharmaceuticals, Inc. | -164.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.86M |
| Cash from Investing (Quarterly) | 8.306M |
| Cash from Financing (Quarterly) | 0.493M |
| Free Cash Flow Per Share (Quarterly) | -0.2088 |
| Free Cash Flow to Equity (Quarterly) | -13.42M |
| Free Cash Flow to Firm (Quarterly) | -12.95M |
| Free Cash Flow Yield | -8.53% |